Corcept Therapeutics (CORT) Interest Expenses (2010 - 2017)
Corcept Therapeutics (CORT) posted Interest Expenses of $11.1 million for Q2 2026, down 3.59% sequentially from $11.5 million in Q1 2026, and up 36.42% YoY from $8.1 million in Q2 2025.
Powered by 
Analysis
Corcept Therapeutics (CORT) Interest Expenses (2010 - 2017) Analysis & Trends
Corcept Therapeutics has reported Interest Expenses for 17 years, with the latest figure at $11.1 million in Q2 2026.
- Quarterly Interest Expenses rose 36.42% year-over-year to $11.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.1 million (up 36.42% YoY) and the FY2025 annual result came in at $20.9 million, up 19.85% from the prior year.
- Interest Expenses declined to $11.1 million in Q2 2026 per CORT's latest filing, from $11.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $17.5 million in Q4 2024 and troughed at $2000.0 in Q4 2025.
- A 5-year average of $7.8 million and a median of $8.4 million in 2022 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 1275.2% in 2025, down 99.99% in 2025.
- Over 5 years, Interest Expenses stood at $2.3 million in 2022, then advanced by 5.56% to $2.4 million in 2023, then soared by 630.24% to $17.5 million in 2024, then tumbled by 99.99% to $2000.0 in 2025, then soared by 553350.0% to $11.1 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $11.1 million, $11.5 million, and $2000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 98,000.00 |
| Mar 31, 2017 | 225,000.00 |
| Dec 31, 2016 | 410,000.00 |
| Sep 30, 2016 | 487,000.00 |
| Jun 30, 2016 | 531,000.00 |
| Mar 31, 2016 | 611,000.00 |
| Dec 31, 2015 | 692,000.00 |
| Sep 30, 2015 | 703,000.00 |
| Jun 30, 2015 | 770,000.00 |
| Mar 31, 2015 | 800,000.00 |
| Dec 31, 2014 | 818,000.00 |
| Sep 30, 2014 | 903,000.00 |
| Jun 30, 2014 | 971,000.00 |
| Mar 31, 2014 | 1.07 Mn |
| Dec 31, 2013 | 1.09 Mn |
| Sep 30, 2013 | 1.17 Mn |
| Jun 30, 2013 | 1.11 Mn |
| Mar 31, 2013 | 1.14 Mn |
| Dec 31, 2012 | 1.14 Mn |
| Sep 30, 2012 | 622,000.00 |